Expert Interview
Investigating Intellia’s CRISPR therapy NTLA-2002 in development for the treatment of swelling attacks in hereditary angioedema (HAE).
Ticker(s): NTLAInstitution: University of Tennessee
- Associate Professor and Director of Allergy & Immunology training at the University of Tennessee.
- Manages 3 patients with Hereditary angioedema.
- Research focuses on food allergy, anaphylaxis, primary immune deficiency, and drug allergy.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
